A61P 1/00

Sub-Class

Watch 7Status Updates

Stats

Description

Class  A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS


Subclass 1/00: Drugs for disorders of the alimentary tract or the digestive system

Recent Patents

Patent #TitleFiling DateIssue DatePatent Owner
10538487 Sulfonylureas and related compounds and use of sameFeb 16, 16Jan 21, 20The University of Queensland; The Provost, Fellows, Foundation Scholars, and the other members of Board, of the College of the Holy and Undivided Trinity of Queen Elizabeth, near Dublin;
10538569 Fusion polypeptide containing GLP and immunoglobulin hybrid Fc and use thereofDec 31, 15Jan 21, 20Genexine, Inc.
10538513 Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitorsJun 28, 19Jan 21, 20Theravance Biopharma R&D IP, LLC
10532061 Farnesoid X receptor modulatorsSep 06, 18Jan 14, 20Intercept Pharmaceuticals Inc.
10532051 Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C-C chemokine receptor 9 (CCR9) and anti-α4β7 integrin blocking antibodiesOct 05, 15Jan 14, 20ChemoCentryx Inc.
10526280 (2-amino-4-(arylamino)phenyl carbamatesNov 13, 15Jan 07, 20University of Pittsburgh—of the Commonwealth System of Higher Education
10517889 Modulators of SMAD7 expressionSep 07, 18Dec 31, 19Ionis Pharmaceuticals, Inc.
10513552 Use of polyclonal antibodies against clostridium difficile for treatment of inflammatory bowel diseaseDec 18, 17Dec 24, 19IMMUNIMED INC.
10513561 Anti-MYL9 antibodyJan 11, 17Dec 24, 19NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY; Eisai R & D Management Co., Ltd.;
10501536 Anti-IL-33 antibodies and uses thereof for disease treatmentOct 24, 17Dec 10, 19Eli Lilly and Company
10493111 Microbiota restoration therapy (MRT), compositions and methods of manufactureJun 22, 17Dec 03, 19REBIOTIX, INC.
10494355 Oxadiazole amine derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the sameOct 11, 16Dec 03, 19CHONG KUN DANG PHARMACEUTICAL CORP.
10485830 Compositions comprising bacterial strainsJun 28, 18Nov 26, 194D Pharma PLC
10487076 Compositions and methods for treating diseases and conditionsDec 10, 15Nov 26, 19University of Pittsburgh—of the Commonwealth System of Higher Education; The United States Government as Represented by the Department of Veterans Affairs;
10487068 Pyridazine derivatives as RORc modulatorsNov 01, 17Nov 26, 19Genentech, Inc.
10485848 Mussel adhesive protein product and use thereof for treating mucosal inflammationAug 15, 16Nov 26, 19JIANGYIN BENGT I. SAMUELSSON INSTITUTE OF LIFE SCIENCE CO., LTD.
10478456 Pharmaceutical preparationDec 18, 09Nov 19, 19Aposcience AG
10473669 Methods for treating inflammatory bowel diseaseMay 08, 15Nov 12, 19Nogra Pharma Limited
10471107 Microbiota restoration therapy (MRT), compositions and methods of manufactureJun 16, 17Nov 12, 19REBIOTIX, INC.
10472405 Multivalent regulatory T cell modulatorsDec 13, 17Nov 12, 19Delinia, Inc.

more results

Recent Publications

Publication #TitleFiling DatePub DatePatent Owner
2019/0358,274 METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMSMay 24, 19Nov 28, 19Not available
2019/0337,897 NOVEL TETRAHYDRONAPHTHYL UREA DERIVATIVEJul 17, 19Nov 07, 19MOCHIDA PHARMACEUTICAL CO. LTD
2019/0330,141 Compositions With A Cooling EffectApr 30, 19Oct 31, 19Not available
2019/0257,833 COMPOSITIONS AND METHODS TO DETECT GASTROINTESTINAL DISEASEFeb 04, 19Aug 22, 19Not available
2019/0256,592 BINDING AGENTS FOR USE IN THERAPYSep 15, 17Aug 22, 19Not available
2019/0256,583 SYSTEMS AND METHODS FOR ALTERING MICROBIOME TO REDUCE DISEASE RISK AND MANIFESTATIONS OF DISEASEJan 22, 19Aug 22, 19Not available
2019/0255,123 COMPOSITIONS COMPRISING BACTERIAL STRAINSSep 28, 18Aug 22, 19Not available
2019/0202,801 PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAMESep 18, 17Jul 04, 19Not available
2019/0192,540 METAL-OLSALAZINE COORDINATION POLYMERS FOR MEDICAL APPLICATIONSDec 04, 18Jun 27, 19The Regents of the University of California
2019/0185,855 CONJUGATED OLIGONUCLEOTIDESAug 11, 17Jun 20, 19Not available
2019/0167,804 GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOFNov 29, 18Jun 06, 19Not available
2019/0083,462 PREVENTION OF NSAID ENTEROPATHY WITH MICROBIOTA-DERIVED TRYPTOPHAN-METABOLITEMar 17, 17Mar 21, 19The Texas A & M University System; The Trustees of Tufts College;
2019/0083,508 USE OF OX1R ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASESNov 23, 15Mar 21, 19Not available
2018/0333,447 BENEFICIAL EFFECTS OF BIDENS PILOSA ON GUT MICROFLORA AND ANIMAL HEALTHNov 21, 16Nov 22, 18Not available
2018/0258,435 BIOSYNTHETIC AMYLOID-BASED MATERIALS DISPLAYING FUNCTIONAL PROTEIN SEQUENCESApr 06, 16Sep 13, 18President and Fellows of Harvard College; President and Fellows of Harvard College;
2018/0250,280 SUBSTITUTED OXOPYRIDINE DERIVATIVESAug 30, 16Sep 06, 18Bayer Pharma Aktiengesellschaft
2018/0214,504 HEALTH SUPPLEMENT FOOD FOR PROMOTION OF HAIR GROWTH, MITIGATION AND ALLEVIATION OF HAIR LOSS, REGULATION OF BLOOD GLUCOSE, AND ALLEVIATION AND RELIEF OF GASTRIC DISORDER SYMPTOMSMar 11, 16Aug 02, 18Not available
2018/0162,869 DRUG DELIVERY AND IMAGING CHEMICAL CONJUGATE, FORMULATIONS AND METHODS OF USE THEREOFJun 15, 16Jun 14, 18Not available
2018/0147,221 GLYCAN THERAPEUTIC COMPOSITIONS AND RELATED METHODS THEREOFApr 23, 16May 31, 18KALEIDO BIOSCIENCES, INC.
2018/0148,770 USE OF MICROBIAL METABOLITES FOR TREATING DISEASESApr 27, 16May 31, 18Not available

more results

Top Owners in This Subclass

Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More

Patents Issued To Date - By Filing Year

Average Time to Issuance